Skip to content

Nasdaq · CIK 0001770787

TXG 10x Genomics, Inc.

Insider trading from SEC Form 4. Last filing 18 d ago. Close $80.65 on Oct 9, 2026, +603% from the 52-week low and -17% from the high.

Last 90 days

Net insider value
-$6.7M
more sold than bought
Buys
0
$0 by 0 insiders
Sells
4
$6.7M by 4 insiders
Insiders on file
9
with a Form 4 at this company

Price and insider trades, last year

TXGOct 9, 2026 · close 80.65

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

Open-market buys and sells at 10x Genomics, Inc., scored.

ScoreInsiderValueHoldingsPrice contextFiled
45ModerateSerge Saxonov
Chief Executive Officer
sell
$2.0M
25,000 shares
-2%+612% from low0% from high
32WeakShehnaaz Suliman
director
sell
$465k
5,723 shares
-19%+612% from low0% from high
47ModerateAdam Taich
Chief Financial Officer
sell
$3.0M
46,388 shares
-13%+493% from low0% from high
48ModerateJohn R Stuelpnagel
director
sell
$1.2M
20,000 shares
-6%+458% from low-3% from high
43ModerateAdam Taich
Chief Financial Officer
sell
$34k
4,044 shares
-1%+20% from low-64% from high
37WeakBenjamin J. Hindson
See Remarks
sell
$62k
7,485 shares
-2%+20% from low-64% from high
49ModerateSerge Saxonov
Chief Executive Officer
sell
$78k
9,343 shares
-1%+20% from low-64% from high
7WeakSerge Saxonov
Chief Executive Officer
sell
$84k
7,942 shares
-1%0% from low-54% from high
40ModerateSerge Saxonov
Chief Executive Officer
sell
$56k
5,092 shares
-1%+4% from low-52% from high
30WeakBenjamin J. Hindson
See Remarks
sell
$51k
4,573 shares
-1%+4% from low-52% from high
60NotableAlan Mateo
director
buy
$446k
40,000 shares
+184%0% from low-54% from high
32WeakBenjamin J. Hindson
See Remarks
sell
$79k
5,807 shares
-2%-
42ModerateSerge Saxonov
Chief Executive Officer
sell
$92k
6,693 shares
-1%-

Transactions

The last 44 rows filed, every code.

DateInsiderTransactionSharesPriceValueHoldings afterFiled
Sep 22, 2026Shehnaaz Suliman
director
SOpen-market sale
Class A Common Stock10b5-1
-292$78.20$23k29,22318 d ago
Sep 22, 2026Serge Saxonov
Chief Executive Officer
SOpen-market sale
Class A Common Stock10b5-1
-1,000$78.23$78k1,074,24918 d ago
Sep 22, 2026Serge Saxonov
Chief Executive Officer
SOpen-market sale
Class A Common Stock10b5-1
-2,000$79.62$159k1,072,24918 d ago
Sep 22, 2026Shehnaaz Suliman
director
SOpen-market sale
Class A Common Stock10b5-1
-614$79.51$49k28,60918 d ago
Sep 22, 2026Serge Saxonov
Chief Executive Officer
SOpen-market sale
Class A Common Stock10b5-1
-9,300$80.90$752k1,062,94918 d ago
Sep 22, 2026Shehnaaz Suliman
director
SOpen-market sale
Class A Common Stock10b5-1
-1,325$80.82$107k27,28418 d ago
Sep 22, 2026Serge Saxonov
Chief Executive Officer
SOpen-market sale
Class A Common Stock10b5-1
-9,900$81.83$810k1,053,04918 d ago
Sep 22, 2026Shehnaaz Suliman
director
SOpen-market sale
Class A Common Stock10b5-1
-2,270$81.67$185k25,01418 d ago
Sep 22, 2026Serge Saxonov
Chief Executive Officer
SOpen-market sale
Class A Common Stock10b5-1
-2,800$82.37$231k1,050,24918 d ago
Sep 22, 2026Shehnaaz Suliman
director
SOpen-market sale
Class A Common Stock10b5-1
-1,222$82.28$101k23,79218 d ago
Sep 9, 2026Adam Taich
Chief Financial Officer
SOpen-market sale
Class A Common Stock10b5-1
-1,206$63.68$77k361,52631 d ago
Sep 9, 2026Adam Taich
Chief Financial Officer
SOpen-market sale
Class A Common Stock10b5-1
-31,428$64.31$2.0M330,09831 d ago
Sep 9, 2026Adam Taich
Chief Financial Officer
SOpen-market sale
Class A Common Stock10b5-1
-13,754$65.26$898k316,34431 d ago
Sep 3, 2026John R Stuelpnagel
director
SOpen-market sale
Class A Common Stock
-7,012$60.66$425k341,42434 d ago
Sep 3, 2026John R Stuelpnagel
director
SOpen-market sale
Class A Common Stock
-6,814$62.11$423k334,61034 d ago
Sep 3, 2026John R Stuelpnagel
director
SOpen-market sale
Class A Common Stock
-6,174$62.61$387k328,43634 d ago
Sep 1, 2026Serge Saxonov
Chief Executive Officer
GGift
Class A Common Stock
-100$0.00$01,075,24939 d ago
Jun 9, 2025Serge Saxonov
Chief Executive Officer
GGift
Class A Common Stock
-1,000$0.00$0955,240Jun 11, 2025
Jun 3, 2025Sarah A. Teichmann
director
AGrant or award
Class A Common Stock
+15,357$0.00$034,359Jun 5, 2025
Jun 3, 2025Shehnaaz Suliman
director
AGrant or award
Class A Common Stock
+15,357$0.00$028,616Jun 5, 2025
Jun 3, 2025John R Stuelpnagel
director
AGrant or award
Class A Common Stock
+15,357$0.00$0359,607Jun 5, 2025
Jun 3, 2025Alan Mateo
director
AGrant or award
Class A Common Stock
+15,357$0.00$077,048Jun 5, 2025
Jun 3, 2025Sridhar Kosaraju
director
AGrant or award
Class A Common Stock
+15,357$0.00$056,449Jun 5, 2025
Jun 3, 2025Kimberly J Popovits
director
AGrant or award
Class A Common Stock
+15,357$0.00$028,616Jun 5, 2025
May 29, 2025Serge Saxonov
Chief Executive Officer
GGift
Class A Common Stock
-3,000$0.00$01,080,625Jun 2, 2025
May 22, 2025Adam Taich
Chief Financial Officer
SOpen-market sale
Class A Common Stock
-4,044$8.30$34k331,588May 27, 2025
May 22, 2025Benjamin J. Hindson
See Remarks
SOpen-market sale
Class A Common Stock
-7,485$8.30$62k448,374May 27, 2025
May 22, 2025Serge Saxonov
Chief Executive Officer
SOpen-market sale
Class A Common Stock
-9,343$8.30$78k1,083,625May 27, 2025
Oct 23, 2024Adam Taich
Chief Financial Officer
AGrant or award
Class A Common Stock
+201,704$0.00$0201,704Mar 19, 2025
Mar 17, 2025Serge Saxonov
Chief Executive Officer
AGrant or award
Class A Common Stock
+171,428$0.00$01,092,968Mar 19, 2025
Mar 17, 2025Benjamin J. Hindson
See Remarks
AGrant or award
Class A Common Stock
+120,535$0.00$0455,859Mar 19, 2025
Mar 17, 2025Adam Taich
Chief Financial Officer
AGrant or award
Class A Common Stock
+133,928$0.00$0335,632Mar 19, 2025
Feb 28, 2025Serge Saxonov
Chief Executive Officer
SOpen-market sale
Class A Common Stock10b5-1
-7,942$10.63$84k871,540Mar 4, 2025
Mar 4, 2025Serge Saxonov
Chief Executive Officer
MOption exercise
Class A Common Stock10b5-1
+50,000$1.20$60k921,540Mar 4, 2025
Mar 4, 2025Serge Saxonov
Chief Executive Officer
MOption exercise
Stock Option (right to buy)derivative10b5-1
-50,000$0.00$017,463Mar 4, 2025
Feb 24, 2025Serge Saxonov
Chief Executive Officer
SOpen-market sale
Class A Common Stock
-5,092$11.07$56k879,482Feb 26, 2025
Feb 24, 2025Benjamin J. Hindson
See Remarks
SOpen-market sale
Class A Common Stock
-4,573$11.07$51k335,324Feb 26, 2025
Feb 21, 2025Alan Mateo
director
POpen-market purchase
Class A Common Stock
+40,000$11.14$446k61,691Feb 25, 2025
Dec 23, 2024Serge Saxonov
Chief Executive Officer
MOption exercise
Class A Common Stock
+12,000$1.20$14k884,574Dec 23, 2024
Dec 23, 2024Serge Saxonov
Chief Executive Officer
MOption exercise
Stock Option (right to buy)derivative
-12,000$0.00$067,463Dec 23, 2024
Nov 22, 2024Benjamin J. Hindson
See Remarks
SOpen-market sale
Class A Common Stock
-5,807$13.69$79k339,897Nov 25, 2024
Nov 21, 2024Serge Saxonov
Chief Executive Officer
GGift
Class A Common Stock
-1,850$0.00$0879,267Nov 25, 2024
Nov 22, 2024Serge Saxonov
Chief Executive Officer
SOpen-market sale
Class A Common Stock
-6,693$13.69$92k872,574Nov 25, 2024
Nov 14, 2024Serge Saxonov
Chief Executive Officer
GGift
Class A Common Stock
-1,350$0.00$0881,117Nov 18, 2024

Insiders

Everyone who has filed a Form 4 here.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

TXG insider trading: 10x Genomics, Inc. | InsiderTell